health and fitness
mardi 5 avril 2022
The F.D.A. Suspends Use of Glaxo Antibody Drug in the U.S.
Manufacturers said lab testing revealed that the authorized dosage of the drug was not sufficiently potent against BA.2.
from NYT > Health https://ift.tt/qVM5PbF
via
health&fitness
Aucun commentaire:
Enregistrer un commentaire
Article plus récent
Article plus ancien
Accueil
Inscription à :
Publier les commentaires (Atom)
Aucun commentaire:
Enregistrer un commentaire